Episode 40: Gilead’s new boss, the year that was, and the thing about DNA tests
Is Gilead Sciences entering a bold new era? What even happened in 2018? And how useful is a genetic credit score?
13 Joulu 201823min
Episode 39: Using the word 'cure,' an FDA loophole, & making biotech history
Can gene therapy cure sickle cell disease? Is an expensive drug better than a free one? And will biotech see its shadow in 2019?
6 Joulu 201822min
Episode 38: Your guide to the #CRISPRbabies controversy
What does it mean to edit a person? Has science run afoul of basic ethics? And what's the time difference to Hong Kong?
29 Marras 201823min
Episode 37: The biggest-ever IPO, drug prices rising in tandem, and burner Twitter accounts
Can unicorns float? Is a hot dog a sandwich? And how are drug companies like gas stations?
15 Marras 201826min
Episode 36: What the midterms mean, a golden age on hold, and the $4 million drug
Is pharma in for a swarm of subpoenas? Are we running out of ideas in oncology? And can a drug possibly be worth $4 million a dose?
8 Marras 201822min
Episode 35: Biotech's October slump, the precise cost of precision, and breaking postpartum silence
Why are biotech stocks in the dumps? Is the latest in cancer care overhyped? And what does "folie à deux" mean?
1 Marras 201826min
Episode 34: Pharma at the ballot box, the latest Alzheimer's argument, and a rare disease dilemma
Can pharma-shaming get someone re-elected? How rare is too rare when it comes to biotech research? And what does "positive" even mean, really?
25 Loka 201821min
Episode 33: Drug prices on TV, immortal blockbusters, and genetic privacy
Are prescription drugs like new cars? Is pharma's grand bargain a sham? And who keeps your DNA safe?
18 Loka 201824min
